Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 885
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: Aurora CO, Duarte CA, Orange CA, Beverly Hills CA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 12 - 70+
Code: NCT03715933
Phase 1, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Location: Aurora CO, Salt Lake City UT, Omaha NE, Bellevue NE,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sex: All
Age: 18+
Code: NCT04031677
Phase 3, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Aurora CO, Greeley CO, Loveland CO, Fort Collins CO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Aurora CO, Saint Paul MN, San Diego CA, Houston TX,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: Male
Age: 2 - 65
Code: NCT06430385
Phase 1, Phase 2, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Aurora CO, Salt Lake City UT, Omaha NE,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase 3, Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Aurora CO, Lone Tree CO, Greeley CO, Loveland CO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase 2, Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Aurora CO, Omaha NE, Phoenix AZ, Dallas TX,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
for
Down Syndrome, Alzheimer Disease, Dementia
Location: Aurora CO, Kansas City KS, Phoenix AZ, St Louis MO,
Sponsor: University of Southern California
Sex: All
Age: 25 - 55
Code: NCT04165109
Recruiting
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
for
Diffuse Cutaneous Systemic Sclerosis
Location: Aurora CO, Oklahoma City OK, Allen TX, Dallas TX,
Sponsor: Mediar Therapeutics
Sex: All
Age: 18+
Code: NCT07287670
Phase 2, Recruiting
Pulmonary Hypertension Association Registry
for
Pulmonary Arterial Hypertension,
Location: Aurora CO, Salt Lake City UT, Kansas City KS,
Sponsor: Pulmonary Hypertension Association, Inc.
Sex: All
Age: 0+
Code: NCT04071327
Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
for
Congenital Adrenal Hyperplasia
Location: Aurora CO, Dallas TX, Minneapolis MN, San Francisco CA,
Sponsor: Neurocrine Switzerland GmbH
Sex: All
Age: 0 - 3
Code: NCT07536269
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Aurora CO, Albuquerque NM, Kansas City KS, Phoenix AZ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07225504
Phase 3, Recruiting
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Location: Aurora CO, St Louis MO, Houston TX, Durham NC,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT04516447
Phase 1, Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment